Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Although ISRG stock trades at a higher valuation of 13x trailing revenues, compared to just 5x for Stryker, this gap in valuation makes sense, in our view, given Intuitive Surgical's superior revenue growth, profitability, and financial position, as discussed below Looking at stock returns, SYK,

Here's Why Intuitive Surgical Stock Is A Better Pick Over Its Peer

Upstart Holdings

If the market dips into bear territory for a prolonged period again, that doesn't mean investors have to head for the hills.

Where to Invest $5,000 in a 2023 Nasdaq Bear Market

Baidu

Okta

Vertex Pharmaceuticals

A 33% plunge in the Nasdaq Composite is the perfect excuse for opportunistic investors to pounce on innovation-driven businesses.

Nasdaq Bear Market: 5 Superb Growth Stocks You'll Regret Not Buying on the Dip

Alphabet

Workday

With many investors looking for ways to capitalize on the potential of AI stocks, this article will look at some of the hottest opportunities out there. After all, the global AI market, worth $119.78 billion in 2022, is forecast to skyrocket to $1,597.1 billion by 2030, with an impressive CAGR of 38.1% over the same period, according to Precedence Research.

The Top 3 AI Stocks to Watch for Big Gains in 2023

Intuitive is revolutionizing minimally invasive care through its range of products and services, with a primary focus on robotic-assisted surgery systems and minimally invasive biopsy systems. The da Vinci Surgical System, the company's flagship product, offers several advantages over traditional surgery, making it a must-have for hospitals.

Intuitive Surgical: Revolutionizing Minimally Invasive Care With Advanced Robotic Systems

Airbnb

The market may have more volatility in store for investors in the coming months, but wonderful stocks can soar over the long haul.

2 Growth Stocks With Multi-Bagger Potential to Buy for 2023

Intuitive Surgical reported Q4 and FY2022 results that fell below expectations as hospitals continue to optimize CapEx in the face of challenging market conditions. Contrary to its customers, ISRG is in the midst of an up CapEx cycle as it prepares to launch next-generation robotic surgical systems.

Intuitive Surgical Beyond Macroeconomic Challenges

Amazon

A prolonged bull market could see these stocks soar.

2 Powerhouse Stocks to Buy in 2023 That Are Ready for a Bull Run

Apple

American Express

Bank of America

Chevron

Dollar General

Disney

Etsy

FedEx

Coca-Cola

MercadoLibre

Realty Income Corp

Pinterest

PayPal

Shopify

Block

Vanguard Total World Stock ETF

Walgreens

Here are 10 stocks that could be excellent additions to your portfolio for the rest of 2023 and for years to come.

Best Stocks To Invest In: February 2023

These healthcare giants are profitable and have wide moats.

2 Top Stocks to Buy in February and Hold Forever

A long-term investment in these stocks could yield generous returns in the years to come.

2 Smart Stocks to Buy and Hold for Years

Should you buy Intuitive Surgical despite the headwinds it's facing right now?

Why Things Could Get Worse Before They Get Better for This Growth Stock

These two companies have historically delivered market-beating returns. They can do the same in the future.

2 Stocks to Buy No Matter What Happens This Year

Automatic Data Processing

Enphase Energy

There's one stock on this list that looks like a strong buy.

Is It Time To Buy the Nasdaq's 3 Worst-Performing January Stocks?

The robotic surgery company is having a rough start to 2023.

Why Intuitive Surgical Stock Slumped in January

Fiverr

Teladoc

A 33% plunge in the Nasdaq Composite is the perfect time to go shopping for game-changing businesses trading at a discount.

Nasdaq Bear Market: 5 Special Growth Stocks You'll Regret Not Buying on the Dip

ASML Hld

Intuit

Microsoft

NVIDIA

Rockwell Automation

NuScale Power Corp

Although the will-it-or-won't-it debate regarding the probabilities of the economy falling into recession dominates business headlines, investors may still want to look ahead with breakthrough technology stocks to buy. These enterprises undergird some of the most groundbreaking innovations of our time, facilitating potentially permanent relevance.

The 7 Most Promising Breakthrough-Technology Stocks to Buy in February

Lululemon Athletica

These stocks are poised for major growth now and over time.

Buy the Dip in 2023 on These Potentially Explosive Stocks

Residual disruption from the pandemic is lasting longer than expected.

Is Intuitive Surgical Stock Still Worth Buying Hand Over Fist in 2023?

ChargePoint Holdings

Datadog

Marathon Digital Holdings

Palo Alto Networks

Unity Software

Growth stocks have had a difficult time of it lately, but there looks to be a comeback brewing. After a tumultuous bear market in 2022, investors are eager for a more stable year.

7 Growth Stocks That Will Be Big Winners in 2023

The initial financial outlook Intuitive Surgical management gave for 2023 was something of a letdown given the stock's high valuation.

Is Intuitive Surgical a Top Healthcare Stock to Buy for 2023?

Intuitive Surgical's (ISRG) fourth-quarter results reflect healthy demand for procedures, partially offset by lower system sales and unfavorable currency. Procedure volume in China suffers.

Intuitive Surgical (ISRG) Falls Following Q4 Earnings Miss

Tesla

Artificial intelligence has been catapulted into the mainstream after the successful launch of OpenAI's ChatGPT. Andrew Rocco breaks down 5 public companies leveraging AI technology to grow their business.

The Coming AI Revolution: 5 Companies at the Forefront

A company in the health-tech space is also seeing its stock fall.

Microsoft's Not the Only Stock Pulling the Nasdaq Lower

Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of -2.38% and 0%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

News for Intuitive Surgical Stock (ISRG)